SECsense Logo

IDEXX Laboratories Inc. 8-K Filing Report: Key Update on Stock Metrics

$IDXX
Form 8-K
Filed on: 2025-05-01
Source
IDEXX Laboratories Inc. 8-K Filing Report: Key Update on Stock Metrics

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: IDEXX Laboratories Inc.
  • CIK Number: 0000874716
  • Address: One IDEXX Drive, Westbrook, ME 04092
  • Ticker Symbol: IDXX
  • Exchange: NASDAQ
  • Par Value of Common Stock: $0.10 per share
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: May 1, 2025
  1. Context Information:
  • Context ID: AsOf2025-05-01
  • Reporting Period: The report is for a single day, May 1, 2025.
  • Unit of Measure:
    • Currency: USD (U.S. Dollar)
    • Shares: The report includes metrics based on shares.
  1. Financial Metrics:
  • Common Stock Outstanding: 207,556.03 shares (Note: This appears to be a fractional share figure, which is atypical; double-check the context for accuracy).
  1. XBRL Specifics:
  • The report utilizes XBRL (eXtensible Business Reporting Language) for structured data representation, which facilitates easier data analysis and integration into financial systems.

Insights:

  • The report is a routine filing (8-K) which typically discloses unscheduled material events or corporate changes. It is important for stakeholders to monitor such filings for potential impacts on the company’s stock performance.
  • The specified par value of common stock indicates the minimum price at which shares can be issued by the company.
  • The reporting of shares in the financial metrics may suggest recent changes in stock structure or program, warranting further investigation into the details surrounding this filing.

Overall, this document may signify an important update concerning IDEXX Laboratories, and stakeholders should review additional filings or news releases for complete context.